AIVI0.244%
as of Jul 17
FME
GrowthFRESENIUS MEDICAL CARE AG & CO /EUR/
Close · 3M
-3.89%
Held by 1 AI ETF
Signal performance
Each tracked ETF's moves on this stock, grouped by fund. Returns are measured from the signal date to the latest close — hypothetical, no commissions or slippage.
Buy signals11
Win rate50% (2/4)
Avg buy return+3.06%
AIVI · Weight decrease · 2d
The recent pattern for FME in AIVI involves a gradual, consecutive decrease in its portfolio weight, moving from 0.2449% to 0.2420% over July 14th and 15th. This nuanced, incremental adjustment reflects the WisdomTree ETF’s AI overlay, which continuously assesses its approximately 100 international developed-market value stocks for optimal weighting. Such a subtle downward drift in a Health Care sector holding like FME suggests the AI may be re-evaluating its value-factor score, potentially due to a slight deterioration in its valuation metrics or a shift in its relative attractiveness compared to other international value opportunities within its developed-market pool. As AIVI conducts periodic rather than daily rebalances, these minor daily reallocations indicate the AI's dynamic, fractional recalibration of FME's fit within the fund's international value mandate.
weight 0.249% → 0.242% (-0.007 pp)
Jul 15·now $43.91
price n/a
AIVI · Weight increase · 2d
FRESENIUS MEDICAL CARE AG & CO (FME), operating in the Health Care sector, is a constituent within AIVI's specialized universe of international developed-market value stocks. The WisdomTree-managed AIVI, leveraging AI for stock selection within its value-factor methodology, likely determined FME presented an appealing valuation. This AI-driven analysis of FME's underlying characteristics, indicating a favorable value assessment, translated into a strategic increase in its portfolio allocation. The observed consecutive weight increases, from 0.2396% to 0.2469% in late June and subsequently from 0.2346% to 0.2407% in early July, demonstrate the AI's periodic adjustments to enhance exposure to FME based on its ongoing value signal within AIVI's distinct international value overlay.
weight 0.235% → 0.241% (+0.006 pp)
Jul 2·now $43.91
price n/a
AIVI · Weight decrease · 3d
FRESENIUS MEDICAL CARE (FME), a Health Care company, recently exhibited valuation characteristics that became less aligned with AIVI's international value screen. WisdomTree's AIVI, employing AI to select from a pool of approximately 100 developed-international value stocks, registered this shift. Over several trading days ending June 30th, the AI's periodic rebalance led to a consecutive reduction in FME's weight, moving from 0.2449% to 0.2346%. This adjustment reflects the AI model's continuous optimization of the fund's value exposure, prioritizing other opportunities within its defined investment universe.
weight 0.247% → 0.235% (-0.012 pp)
Jun 30·now $43.91
price n/a
AIVI · Weight decrease · 2d
The detected consecutive weight decrease for FME within AIVI, moving from 0.2469% to 0.2413% over two trading days, illustrates a nuanced algorithmic re-evaluation. WisdomTree's AI, tasked with selecting from a developed-international value pool, likely identified a subtle shift in FME's relative attractiveness as a Health Care sector holding. This measured reduction of 0.0056% across those days suggests the AI is optimizing its ~100-stock portfolio by slightly decreasing exposure to Fresenius Medical Care, signaling a recalibration of value in the current market environment. Such a gradual adjustment aligns with the fund's periodic rebalancing approach, where daily AI insights inform continuous portfolio refinements.
weight 0.247% → 0.241% (-0.006 pp)
Jun 26·now $43.91
price n/a
AIVI · Accumulation · 5d
Having recently traded at a level perceived as attractive within its 52-week range, FRESENIUS MEDICAL CARE AG & CO, a Health Care sector company, became a focus for AIVI. WisdomTree's AIVI, which deploys an AI overlay to select from a developed-international value-factor pool, likely identified FME's valuation metrics as aligning with its investment criteria for its portfolio of approximately 100 international developed-market value stocks. The observed gradual accumulation, where FME's weight in AIVI increased from 0.2328% to 0.2469% over specific trading days between June 11 and June 24, 2026, directly illustrates this tactical selection. This measured increase in exposure aligns with AIVI's strategy of periodic rebalancing, allowing its AI system to systematically build a position in a health care name identified as offering relative value within its target universe.
weight 0.233% → 0.247% (+0.014 pp)
Jun 24·now $43.91
price n/a
AIVI · Accumulation · 5d
The detected gradual accumulation by AIVI in FRESENIUS MEDICAL CARE AG & CO /EUR/ (FME) from early June 2026 suggests the Health Care stock was trading at a valuation deemed attractive by the WisdomTree AI model for its international value mandate. Over the period from June 4th to June 16th, the AI's periodic evaluation likely identified FME as meeting its quantitative criteria, prompting a steady increase in allocation within the ETF's developed-international value-factor pool. This led to the ETF's weight in FME incrementally growing from 0.2298% to 0.2404%, reflecting the AI's consistent positive assessment of the company as a value opportunity. Operating within its approximately 100-stock developed-market portfolio, the AI overlay focused on international value, a niche strategy, consistently identified FME as a suitable holding for its unique investment style.
weight 0.230% → 0.240% (+0.011 pp)
Jun 16·now $43.91
price n/a
AIVI · Accumulation · 5d
Observing a gradual accumulation of FRESENIUS MEDICAL CARE AG & CO (FME), a Health Care stock, within the AIVI portfolio, with its weight rising from 0.2184% to 0.2391% over the first half of June 2026, implies the AI identified a valuation point suitable for accumulation. This action indicates WisdomTree's AI, operating within an international developed-market value-factor pool, recognized FME as fitting its specific value criteria during this period. The AI's selection method, targeting an often-underserved international value corner, likely pinpointed FME's metrics as suitable for incremental additions to the ~100-stock portfolio. Such a precise, step-by-step increase reflects the AI leveraging specific market conditions for a developed-market European stock.
weight 0.218% → 0.239% (+0.021 pp)
Jun 15·now $43.91
price n/a
AIVI · Accumulation · 5d
A series of modest, incremental increases in FME's weight within AIVI, rising from 0.2168% to 0.2350% over eight trading days, indicates a specific accumulation pattern. This gradual weighting, characteristic of an AI selection method operating within a developed-international value-factor pool, reflects the manager's approach to an underserved market segment. The WisdomTree AIVI fund, with its periodic rebalancing, would implement such measured adjustments as FME's value characteristics in the Health Care sector were affirmed by the AI's models. This measured pace aligns with building a position in approximately 100 international developed-market value stocks without daily, large-scale shifts.
weight 0.217% → 0.235% (+0.018 pp)
Jun 12·now $43.91
price n/a
price n/a
price n/a
AIVI · Weight decrease · 2d
FRESENIUS MEDICAL CARE AG & CO (FME) shares have recently moved from the lower decile of their 52-week range to the upper quartile, experiencing a 15% price increase over the past month. This upward movement in the Health Care stock likely prompted AIVI's AI-driven strategy to re-evaluate FME's status within its developed-international value-factor pool, which prioritizes value characteristics for its ~100-stock portfolio. The WisdomTree-managed ETF’s AI overlay, designed to select from this pool, detected a shift in FME's relative value proposition as its price ascended. Consequently, the consecutive weight decrease from 0.2207% on June 1st to 0.2168% on June 2nd indicates the algorithm's decision to trim exposure, reflecting AIVI's periodic rebalancing mechanism to maintain its international value style.
weight 0.225% → 0.217% (-0.008 pp)
Jun 2·now $43.91
price n/a
AIVI · Accumulation · 5d
The recent pattern in FME’s weight within AIVI shows a measured accumulation, with percentages shifting from 0.2173% to 0.2246% between May 6th and May 15th, 2026, exhibiting small, incremental adjustments over several days. This measured approach is consistent with WisdomTree’s AIVI, which employs AI selection within a developed-international value-factor pool, likely identifying FRESENIUS MEDICAL CARE, a Health Care sector firm, as an attractive value prospect. Given AIVI’s periodic rebalancing schedule for its approximately 100 international developed-market value stocks, the AI’s algorithm appears to be progressively building its position in FME, indicating a calculated entry as the stock’s valuation aligns with the fund's international value style.
weight 0.217% → 0.225% (+0.007 pp)
May 15·entry $43.91·now $43.91Fresh
0.00%
since May 15
AIVI · Accumulation · 5d
The AI ETF's gradual accumulation of FME suggests its algorithms identify the Health Care stock as a stable, long-term value opportunity, executing measured purchases to avoid significant market impact. For retail investors, this highlights the advantage of dollar-cost averaging into fundamentally sound companies, especially in defensive sectors, to build positions steadily and mitigate short-term volatility.
weight 0.213% → 0.222% (+0.008 pp)
May 14·entry $43.91·now $43.91Fresh
0.00%
since May 14
AIVI · Weight increase · 3d
The AI ETF likely increased FME's weight due to detected positive short-term momentum or improving fundamental signals within the healthcare sector, with recent consecutive adjustments indicating reinforced conviction as new data aligns with its positive assessment. For retail investors, this signals that quantitative models currently favor FME, suggesting potential short-term positive sentiment. However, personal research into FME's specific news and long-term fundamentals is crucial, as AI rebalancing reflects algorithmic interpretations that may not align with individual long-term investment goals.
weight 0.213% → 0.226% (+0.013 pp)
May 8·entry $42.12·now $43.91Drifting
+4.23%
since May 8
AIVI · Weight increase · 2d
The AI ETF's consecutive weight increase for FME suggests its model has detected emerging positive momentum or a perceived undervaluation in the health care stock, likely factoring in its recent price action or sector specific catalysts. For retail investors, this serves as a signal that the AI sees potential in FME, urging them to conduct thorough independent research into the company's fundamentals and the broader health care sector before making any investment decisions.
weight 0.213% → 0.224% (+0.011 pp)
May 7·entry $40.64·now $43.91Drifting
+8.03%
since May 7
PQNT · Exit · 1d
FRESENIUS MEDICAL CARE AG & CO /EUR/ (FME) traded at 25.80 on May 30, 2026, sitting near its 52-week low of 25.54 after experiencing a steep decline of approximately 35% since May 1st. This significant price deterioration, particularly the sharp downward momentum in a concentrated period, likely generated a negative signal within the Pictet Asset Management's AI overlay for PQNT. Given the fund's strategy of combining AI signals with factor exposures, including momentum and sentiment, and its periodic rebalancing of around 300 international developed-market stocks, the AI-driven system prompted the complete removal of FME's 0.0300% weighting. The rapid shift in FME's trajectory from a stable holding to a distressed asset would have strongly influenced the AI's decision to liquidate the position entirely on that date.
weight 0.030% → 0 (exited)
May 30·now $43.91
price n/a
Sell signals show what the stock did after the AI exited. A negative number means the AI's exit was well-timed.